SLS Services Limited
LinuxRecruit
BioMarin Pharmaceutical Inc.
University Hospital of North Midlands NHS Trust
Connect with headhunters to apply for similar jobsUniversity of Wolverhampton
Chartered Institute of Procurement and Supply (CIPS)
Bedfordshire Hospitals NHS Foundation Trust
Isomorphic Labs
Orchard Therapeutics
University Hospital of North Midlands NHS Trust
A pioneering biotechnology firm in the UK is seeking a dynamic Director/Senior Director of CMC to guide key programs for First-in-Man clinical trials and commercialization of products. This role involves overseeing upstream process development and CMC strategy. The ideal candidate will have proven experience in cell and gene therapy and strong leadership skills. Join a fast-paced, innovative environment to drive cutting-edge technology advancement.
A highly anticipated Cell & Gene Therapy biotech, well-funded and experiencing significant growth, is looking for a dynamic Director/Senior Director of CMC (Chemistry, Manufacturing, and Controls) to join their expanding team. This role presents a unique opportunity to be a part of a pioneering organization at the forefront of next-generation technology within the Cell & Gene Therapy space.
As the Director of CMC, you will play a critical role in the leadership team, guiding the strategy and execution of key programs focused on enabling First-in-Man clinical trials, late-stage clinical trials, and commercialization of both internal and partnered product and platform technologies.
This opportunity is perfect for someone with a genuine passion for innovation and a drive to work on cutting-edge technologies within the biotech field. If you meet the key criteria and are ready to take the next step in your career, we encourage you to apply.
Best of luck!
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.